192 related articles for article (PubMed ID: 19051574)
1. Risks and benefits of antipsychotic drugs in elderly patients with dementia.
Howland RH
J Psychosoc Nurs Ment Health Serv; 2008 Nov; 46(11):19-23. PubMed ID: 19051574
[TBL] [Abstract][Full Text] [Related]
2. Antipsychotic treatment of psychosis and agitation in the elderly.
Daniel DG
J Clin Psychiatry; 2000; 61 Suppl 14():49-52. PubMed ID: 11154017
[TBL] [Abstract][Full Text] [Related]
3. Elderly patients with dementia-related symptoms of severe agitation and aggression: consensus statement on treatment options, clinical trials methodology, and policy.
Salzman C; Jeste DV; Meyer RE; Cohen-Mansfield J; Cummings J; Grossberg GT; Jarvik L; Kraemer HC; Lebowitz BD; Maslow K; Pollock BG; Raskind M; Schultz SK; Wang P; Zito JM; Zubenko GS
J Clin Psychiatry; 2008 Jun; 69(6):889-98. PubMed ID: 18494535
[TBL] [Abstract][Full Text] [Related]
4. Effects of risperidone on behavioral and psychological symptoms associated with dementia in clinical practice.
Kurz A; Schwalen S S; Schmitt A
Int Psychogeriatr; 2005 Dec; 17(4):605-16. PubMed ID: 16185378
[TBL] [Abstract][Full Text] [Related]
5. Risperidone for the treatment of behavioral and psychological symptoms of dementia.
Tune LE
J Clin Psychiatry; 2001; 62 Suppl 21():29-32. PubMed ID: 11584986
[TBL] [Abstract][Full Text] [Related]
6. [Antipsychotic drug therapy for patients with behavioral and psychological symptoms of dementia(BPSD)].
Kudo T
Seishin Shinkeigaku Zasshi; 2007; 109(7):657-63. PubMed ID: 17969953
[No Abstract] [Full Text] [Related]
7. Psychotic symptoms, aggression and restlessness in dementia.
Ballard C; Gray A; Ayre G
Rev Neurol (Paris); 1999; 155 Suppl 4():S44-52. PubMed ID: 10637938
[TBL] [Abstract][Full Text] [Related]
8. Atypical antipsychotics for the treatment of dementia-related behaviors: an update.
Daiello LA
Med Health R I; 2007 Jun; 90(6):191-4. PubMed ID: 17633594
[TBL] [Abstract][Full Text] [Related]
9. Agitation and psychosis in dementia.
Ballard C
Am J Geriatr Psychiatry; 2007 Nov; 15(11):913-7. PubMed ID: 17974863
[No Abstract] [Full Text] [Related]
10. Antipsychotic use in dementia: the relationship between neuropsychiatric symptom profiles and adverse outcomes.
Mueller C; John C; Perera G; Aarsland D; Ballard C; Stewart R
Eur J Epidemiol; 2021 Jan; 36(1):89-101. PubMed ID: 32415541
[TBL] [Abstract][Full Text] [Related]
11. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
[TBL] [Abstract][Full Text] [Related]
12. Antipsychotic drugs for psychosis and agitation in dementia: efficacy, safety, and a possible noradrenergic mechanism of action.
Raskind MA; Wang LY
Int Psychogeriatr; 2014 Jun; 26(6):879-83. PubMed ID: 24703502
[No Abstract] [Full Text] [Related]
13. [Antipsychotics in geriatric institutions].
Szulik J
Vertex; 2007; 18(76):454-60. PubMed ID: 18273435
[TBL] [Abstract][Full Text] [Related]
14. Management of Dementia-Related Psychosis, Agitation and Aggression: A Review of the Pharmacology and Clinical Effects of Potential Drug Candidates.
Marcinkowska M; Śniecikowska J; Fajkis N; Paśko P; Franczyk W; Kołaczkowski M
CNS Drugs; 2020 Mar; 34(3):243-268. PubMed ID: 32052375
[TBL] [Abstract][Full Text] [Related]
15. Preventing aggression in persons with dementia.
Nguyen VT; Love AR; Kunik ME
Geriatrics; 2008 Nov; 63(11):21-6. PubMed ID: 18998764
[TBL] [Abstract][Full Text] [Related]
16. Report on an open-label prospective study of divalproex sodium for the behavioral and psychological symptoms of dementia as monotherapy and in combination with second-generation antipsychotic medication.
Forester B; Vanelli M; Hyde J; Perez R; Ahokpossi C; Sribney W; Adkison L
Am J Geriatr Pharmacother; 2007 Sep; 5(3):209-17. PubMed ID: 17996660
[TBL] [Abstract][Full Text] [Related]
17. Ziprasidone for agitation or psychosis in dementia: four cases.
Cole SA; Saleem R; Shea WP; Sedler M; Sablosky M; Jyringi D; Smith A
Int J Psychiatry Med; 2005; 35(1):91-8. PubMed ID: 15977947
[TBL] [Abstract][Full Text] [Related]
18. Behavioral and psychological symptoms of dementia (BPSD) in elderly demented subjects: is the long lasting use of atypical antipsychotic drugs useful and safe?
Angelini A; Bendini C; Neviani F; Neri M
Arch Gerontol Geriatr; 2007; 44 Suppl 1():35-43. PubMed ID: 17317431
[TBL] [Abstract][Full Text] [Related]
19. Consequences of antipsychotic medications for the dementia patient.
Devanand DP; Schultz SK
Am J Psychiatry; 2011 Aug; 168(8):767-9. PubMed ID: 21813491
[No Abstract] [Full Text] [Related]
20. Pharmacological treatment of psychosis and agitation in elderly patients with dementia: four decades of experience.
Kindermann SS; Dolder CR; Bailey A; Katz IR; Jeste DV
Drugs Aging; 2002; 19(4):257-76. PubMed ID: 12038878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]